Cytokines are small secreted proteins that carry signals between cells, and they fall into seven major families: interleukins, interferons, tumor necrosis factors, chemokines, colony-stimulating factors, transforming growth factor beta, and growth factors. Each family binds a distinct receptor class and triggers a specific signaling route, such as JAK-STAT for interleukins or the caspase cascade for TNF. This list separates the families by receptor structure and function, because receptor architecture, not the name, predicts what a cytokine does. A reader who stops here knows the seven groups and the logic that organizes them.

What a cytokine family actually is, and why receptor structure decides

Cytokine families are defined by shared receptor architecture and downstream signaling, not by the name printed on the protein. Two cytokines called interleukins can sit in different families if their receptors use different machinery. The organizing principle is the receptor.

Four signaling routes cover most of the field. Type I cytokines signal through JAK-STAT. The interferon family uses a related JAK-STAT path with different STAT pairs. The TNF superfamily recruits TRAF adaptors and activates NF-kB. Chemokines signal through G-protein-coupled receptors, which is why they act fast and locally.

In plain terms: the receptor is the family crest, and the STAT protein or kinase it recruits is the family name.

This matters clinically. A drug that blocks one interleukin receptor often spares cytokines in other families, which is why targeted biologics produce narrower side-effect profiles than broad immunosuppression.

Complete list of cytokine families with functions

Seven families cover almost all cytokine biology. The table below gives the defining receptor, the core function, and a representative member for each.

Family Defining receptor and signal Core function Representative member
Interleukins Type I/II cytokine receptors, JAK-STAT Immune coordination, inflammation, lymphocyte growth IL-6, IL-1, IL-2
Interferons Type I/II/III IFN receptors, JAK-STAT Antiviral defense, MHC upregulation IFN-alpha, IFN-gamma
TNF superfamily TNF receptor, NF-kB via TRAF Inflammation, apoptosis, lymphoid organ development TNF-alpha, FasL
Chemokines G-protein-coupled receptors Directed leukocyte migration CXCL8, CCL2
Colony-stimulating factors Type I receptors, JAK-STAT Myeloid cell proliferation and differentiation G-CSF, M-CSF
TGF-beta family Serine/threonine kinase receptors, SMAD Growth inhibition, immune tolerance, fibrosis TGF-beta1
Growth factors Receptor tyrosine kinases Proliferation, survival, tissue repair EGF, VEGF, PDGF

Interleukins alone number more than 40 distinct proteins, and the count keeps rising as new members are assigned. That is why no clinician memorizes the list. The families are the useful unit.

Interleukins and interferons: the immune coordination network

Interleukins are the largest and messiest family. Members range from IL-1, a master alarm cytokine, to IL-2, which drives T-cell expansion. Receptor class splits them further: the IL-1 family uses Toll/IL-1 receptor domains, while most others use the shared gamma chain or gp130 subunit.

The shared subunit is the clinical trap. IL-2, IL-4, IL-7, IL-9, and IL-15 all borrow the common gamma chain. A mutation in that chain causes X-linked severe combined immunodeficiency, because five cytokine signals fail at once. One broken receptor disables an entire signaling neighborhood.

Interferons split into three types. Type I (alpha and beta) is induced by viral RNA and peaks within hours of infection. Type II is a single cytokine, IFN-gamma, made by T cells and natural killer cells. Type III interferons act mainly at epithelial barriers.

A non-obvious detail: interferon therapy for hepatitis C has largely been replaced by direct-acting antivirals, but interferon-alpha still appears in oncology and in a handful of rare diseases. The family did not lose relevance; it lost market share.

TNF, chemokines, and colony-stimulating factors: inflammation, traffic, and supply

The TNF superfamily has more than 18 ligands and 29 receptors in humans, and it controls both inflammation and programmed cell death. TNF-alpha is the archetype, but the family also includes FasL, which triggers apoptosis, and BAFF, which keeps B cells alive.

Chemokines are the smallest cytokines, typically 8 to 12 kilodaltons. Their GPCR signaling allows a leukocyte to sense a gradient and move up it within minutes. CXCL8 (also called IL-8) recruits neutrophils; CCL2 recruits monocytes. The chemokine system has around 50 ligands and 20 receptors, and the redundancy is deliberate.

Colony-stimulating factors keep the myeloid supply chain running. G-CSF drives neutrophil production and is used clinically to recover white counts after chemotherapy, typically raising neutrophil counts within 24 to 48 hours. M-CSF supports macrophage lineage commitment.

In plain terms: TNF starts the fight, chemokines call the cells, and colony-stimulating factors build the army.

A time course of cytokine response, from injury to resolution

Cytokine action follows a predictable clock. The timeline below shows the sequence after a typical localized infection or tissue injury.

Time after insult Dominant cytokines What happens
0 to 30 minutes Preformed TNF-alpha, IL-1 Resident macrophages release stored signals
1 to 4 hours IL-6, CXCL8, type I interferon Fever, neutrophil recruitment, antiviral state
6 to 24 hours IL-12, IFN-gamma T-cell and NK-cell activation
2 to 5 days IL-2, IL-4, IL-10 Adaptive expansion, early restraint
5 to 14 days TGF-beta, IL-10 Resolution, tissue repair
Weeks to months Low-level IL-6, TGF-beta Fibrosis or chronic inflammation if unresolved

The clock is not fixed. Sepsis compresses the early phase into hours and can drive IL-6 into the thousands of picograms per milliliter, versus a normal plasma level under about 5 picograms per milliliter. That thousand-fold gap is the quantified difference between local and systemic inflammation.

Dysregulated cytokine families: cytokine storm and chronic inflammation

When cytokine families fire without restraint, the result is a cytokine storm. The defining feature is a self-amplifying loop: IL-1 and TNF-alpha recruit more immune cells, which release more IL-6 and IFN-gamma. Ferritin above 10,000 nanograms per milliliter is a recognized marker of severe storm in conditions like hemophagocytic lymphohistiocytosis.

Chronic low-grade elevation is subtler but more common. Persistent IL-6 above roughly 3 picograms per milliliter correlates with insulin resistance and cardiovascular risk in population studies. That threshold is well below the storm range, which is why chronic inflammation is easy to miss on a single lab draw.

Autoimmune disease maps onto specific families. Rheumatoid arthritis is TNF- and IL-6-driven. Psoriasis leans on IL-23 and IL-17. Lupus involves type I interferon. Each mapping explains why a drug that works in one disease fails in another.

Common misconceptions about cytokine families

Cytokines are often described as hormones of the immune system, but that analogy breaks in one important way. Hormones travel through the bloodstream to distant targets. Most cytokines act locally, over distances of micrometers, and degrade within minutes in plasma. Systemic cytokine levels therefore understate what is happening in tissue.

A second misconception is that more cytokine means more inflammation. IL-10 and TGF-beta are anti-inflammatory, and blocking them can worsen disease. The net effect depends on the balance, not the absolute count.

A third: the names are historical, not functional. IL-8 was reclassified as a chemokine, so the same molecule sits in two naming systems. Reading a cytokine panel requires knowing both.

What to actually do with this information

Use the families as a map, not a memorization list. The practical actions differ by context.

  • When reading a cytokine panel, group results by family before interpreting single values.
  • Treat a ferritin above 10,000 nanograms per milliliter with elevated IL-6 as a red flag for cytokine storm and escalate urgently.
  • Remember that plasma cytokine levels lag tissue events by hours, so a normal level does not rule out local inflammation.
  • Match biologic choice to the dominant family, not to the disease label.
  • Expect anti-inflammatory cytokines to rise during resolution, and do not read that as worsening disease.

Red-flag warning signs that call for immediate clinical review:

  • Fever above 104 degrees Fahrenheit with ferritin above 10,000 nanograms per milliliter.
  • Rapidly rising IL-6 alongside falling blood pressure.
  • Cytopenias plus high triglycerides suggesting hemophagocytic syndrome.
  • New organ dysfunction within 48 hours of a triggering infection.

Limits of the family model and open questions

The seven-family framework is a scaffold, not a complete map. Some cytokines fit poorly. IL-1 belongs to an ancient family with its own receptor logic and is often listed separately despite the interleukin name. Adipokines and some growth factors blur the line between cytokine and hormone.

The biggest unresolved question is redundancy. Knocking out a single cytokine in mice often produces mild phenotypes because family members compensate. Human disease sometimes behaves the same way and sometimes does not, and predicting which is still unreliable.

Finally, the field is moving toward spatial and single-cell measurement. Bulk plasma panels cannot see the micrometer-scale signaling that defines most cytokine action. The family list will remain useful, but the next decade of data will likely reorganize it around tissue context rather than receptor class.